S32

S32 is a venture capital firm investing at the frontiers of technology, healthcare and the life sciences with focus areas including biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence. The firm’s goal is to improve the human condition by accelerating the discovery, development, adoption and distribution of important technologies and life saving medicines. Bill Maris, Founder Andy Harrison, CEO & Managing Partner Mike Pellini MD, Managing Partner Steve Kafka PhD, Managing Partner Ainhoa Maiz, Senior Principal Vivian Chao, Controller Alice Cheung, Head of Talent Vanessie Christensen, Operations Evalynne Dacayanan, Operations Kenzo Fong Hing, Advisor Nina Labatt, Chief Financial Officer & Chief Operating Officer Sarah Larson, Advisor Brittany Schnaars, Operations Kimberly Shih, Talent Director Carlos Solórzano, Senior Principal Wesley Tillu, Senior Principal Tom Zhang, Head of Data Follow us on Twitter: https://twitter.com/S32_VC